Protease inhibitors (ritonavir and saquinavir) were added to the treatment and the patient developed progressive ataxia related to carbamazepine toxicity.
carbamazepine toxicity
saquinavir
progressive ataxia
ritonavir
carbamazepine toxicity
carbamazepine
progressive ataxia
carbamazepine
carbamazepine toxicity
ritonavir
progressive ataxia
saquinavir